← Back to screener

Twist Bioscience Corp TWST

Rank #2291 · Nasdaq · $9.5B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
25.6
P/E
-46.5
P/B
12.05
ROE
-25.9%
Op. Margin
-88.6%
Debt Ratio
18%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Weak

P/E -46.5x, P/B 12.05x. Ranks in the top 78% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -25.9%. Ranks in the top 86% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 18%. Ranks in the top 12% of the universe. Under 100% is generally considered a safe level.

Growth ★★★★☆
Excellent

Revenue growth of 20.4% year over year. Ranks in the top 18% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2019$0.0B$-0.1B$-0.1B$-0.1B-543.2-35
2020$0.0B$-0.1B$-0.1B$-0.1B-277.5-26
2021$0.1B$-0.1B$-0.1B$-0.2B-200.1-31
2022$0.1B$-0.1B$-0.1B$0.2B-155.580
2023$0.1B$-0.2B$-0.2B$0.3B-115.451
2024$0.2B$-0.2B$-0.2B$0.6B-115.326
2025$0.2B$-0.2B$-0.2B$0.8B-88.618

← See the full screener